FDA Inspection 788913 — Center for Fertility and Reproductive Endocrinology UPP
The FDA completed an inspection of Center for Fertility and Reproductive Endocrinology UPP on June 25, 2012 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Pittsburgh, PA (United States)